To find out whether TNuF could improve these adverse effects in tumor-bearing mice, we measured the murine blood cell counts, lean body weight, skeletal muscles, and fat tissue, together with serum levels of tumor necrosis factor alpha (TNF-α), interleukin 1 beta (IL-1β), and interleukin 6 (IL-6) during sacrifice (Table 1). The gene discussed is IL1B; the disease is neoplasm.